Bios Capital Management, LP Cognition Therapeutics Inc Transaction History
Bios Capital Management, LP
- $95.9 Billion
- Q4 2024
A detailed history of Bios Capital Management, LP transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Bios Capital Management, LP holds 6,000,000 shares of CGTX stock, worth $2.64 Million. This represents 4.39% of its overall portfolio holdings.
Number of Shares
6,000,000Holding current value
$2.64 Million% of portfolio
4.39%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$970,3650.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$545,4090.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$270,3750.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$220,0000.0% of portfolio
-
Voss Capital, LLC Houston, TX500KShares$220,0000.03% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.99M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...